Barriers to rapid containment of the #Ebola outbreak

By August 11, 2014, a total of 170 healthcare workers has been infected, 81 have died. 

The outbreak of Ebola virus disease in west Africa continues to evolve in alarming ways, with no immediate end in sight. Many barriers stand in the way of rapid containment.

The Ebola virus is highly contagious, but is not airborne. Transmission requires close contact with the bodily fluids of an infected person, as can occur during health-care procedures, home care, or traditional burial practices, which involve the close contact of family members and friends with bodies. 

ESPAÑOL:

El virus del Ebola es uno de los patógenos más virulentos. El equipo de protección personal es esencial, pero escasea. Además es caliente e incómodo, y limita mucho el número de horas que el personal médico y de enfermería puede trabajar en una planta de aislamiento. Según las estimaciones actuales, un centro en el que se estén tratando 70 pacientes necesitará como mínimo 250 profesionales sanitarios.

Ahora que el brote ha cumplido 6 meses, se comprueba que el miedo es el obstáculo más difícil de vencer. El miedo hace que los contactos de los casos escapen al sistema de vigilancia, que las familias escondan a los parientes con síntomas o los lleven a curanderos tradicionales, y que los pacientes huyan de los centros terapéuticos. El miedo y la hostilidad que este puede alimentar han puesto en peligro la seguridad de los equipos de respuesta nacionales e internacionales.

El personal sanitario teme por sus vidas. Hasta la fecha se han infectado más de 170 profesionales sanitarios y al menos 81 han fallecido.

REFERENCE:

WHO Barriers to rapid containment of the #Ebola outbreak

En español: http://www.who.int/csr/disease/ebola/overview-august-2014/es/
-----------------------------------------------------------

Sigue este Blog en Facebook y Twitter
  

CDC´s #Ebola Virus Disease Information for Clinicians

The Centers for Disease Control and Prevention is working closely with the World Health Organization and other partners to better understand and manage the public health risks posed by Ebola virus disease (EVD). As of August 10, 2014, no EVD cases have occurred in the United States. The purpose of this document is to provide updated information about EVD to clinicians working in U.S. hospitals and health clinics. Includes:

• Clinical Presentation and Clinical Course
• Pathogenesis
• Laboratory Findings
• Initial evaluation of patients known or suspected to have EVD
• Treatment

REFERENCE:
Ebola Virus Disease Information for Clinicians in U.S. Healthcare Settings

VEA TAMBIEN:
La OPS/OMS llama a países de las Américas a estar vigilantes y prepararse ante la potencial introducción del virus del Ébola
-----------------------------------------------------------
Follow us in Facebook & Twitter

Decontamination Efficacy Sporicidal Disinfectants Contaminated with Spores of #anthrax

In the event of a wide area release and contamination of a biological agent in an outdoor environment and to building exteriors, decontamination is likely to consume the Nation's remediation capacity, requiring years to cleanup, and leading to incalculable economic losses. This is in part due to scant body of efficacy data on surface areas larger than those studied in a typical laboratory (5×10-cm), resulting in low confidence for operational considerations in sampling and quantitative measurements of prospective technologies recruited in effective cleanup and restoration response. In addition to well-documented fumigation-based cleanup efforts, agencies responsible for mitigation of contaminated sites are exploring alternative methods for decontamination including combinations of disposal of contaminated items, source reduction by vacuuming, mechanical scrubbing, and low-technology alternatives such as pH-adjusted bleach pressure wash. If proven effective, a pressure wash-based removal of Bacillus anthracis spores from building surfaces with readily available equipment will significantly increase the readiness of Federal agencies to meet the daunting challenge of restoration and cleanup effort following a wide-area biological release. In this inter-agency study, the efficacy of commercial-of-the-shelf sporicidal disinfectants applied using backpack sprayers was evaluated in decontamination of spores on the surfaces of medium-sized (∼1.2 m2) panels of steel, pressure-treated (PT) lumber, and brick veneer. Of the three disinfectants, pH-amended bleach, Peridox, and CASCAD evaluated; CASCAD was found to be the most effective in decontamination of spores from all three panel surface types.
REFERENCE:
Edmonds JM, Sabol JP, Rastogi VK. Decontamination efficacy of three commercial-off-the-shelf (COTS) sporicidal disinfectants on medium-sized panels contaminated with surrogate spores of Bacillus anthracis. PLoS One. 2014 Jun 18;9(6):e99827.

-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter

Guías y hojas para el manejo del #ébola

A number of guidelines and training tools are available from the WHO and have been posted on the emerging issues resources section of the International Federation of Biosafety Associations (IFBA) website as follows:

• Infection Control Recommendations for Patients with Suspected Viral Haemorrhagic Fever
• Infection Control for Viral Haemorrhagic Fevers in African HealthCare Setting
• Infection Control for Viral Haemorrhagic Fevers in African HealthCare Setting (French version)
• Aide-Memoire for Infection Prevention & Control in a HealthCare Facility
• 5 Moments of Hand Hygiene
• 5 Moments of Handy Hygiene (French version)
• The African Society for Laboratory Medicine (ASLM) will also be posting additional resources materials on their website at www.aslm.org.
• Ebola Virus Disease: Implications of Introduction to the Americas
• Ebola Virus Disease: Implications of Introduction to the Americas (Spanish Version)
• Ebola and Marburg Virus Disease Epidemics: Preparedness, Alert, Control and Evaluation

---------------------------------------------------------
En la página de la Organización Panamericana de la Salud pueden encontrar adicionalmente los siguientes materiales:

• Página principal de Ébola WHO
• Hoja informativa
• Brotes epidémicos por ébola
• Preguntas frecuentes sobre la enfermedad por el virus del Ebola
• Recomendaciones para viajeros (sólo en inglés)
• Recomendaciones para las autoridades de salúd pública y sector transporte (sólo en inglés)
• 8 de agosto del 2014 - Declaración de la OMS sobre la Reunión del Comité de Emergencia del Reglamento Sanitario Internacional

-----------------------------------------------------------

Sigue este Blog en Facebook y Twitter

#LIBRO: Science Needs for Microbial Forensics

Microbial forensics is a scientific discipline dedicated to analyzing evidence from a bioterrorism act, biocrime, or inadvertent microorganism or toxin release for attribution purposes. This emerging discipline seeks to offer investigators the tools and techniques to support efforts to identify the source of a biological threat agent and attribute a biothreat act to a particular person or group. Microbial forensics is still in the early stages of development and faces substantial scientific challenges to continue to build capacity.
The unlawful use of biological agents poses substantial dangers to individuals, public health, the environment, the economies of nations, and global peace. It also is likely that scientific, political, and media-based controversy will surround any investigation of the alleged use of a biological agent, and can be expected to affect significantly the role that scientific information or evidence can play. For these reasons, building awareness of and capacity in microbial forensics can assist in our understanding of what may have occurred during a biothreat event, and international collaborations that engage the broader scientific and policy-making communities are likely to strengthen our microbial forensics capabilities. One goal would be to create a shared technical understanding of the possibilities - and limitations - of the scientific bases for microbial forensics analysis.
REFERENCE:
National Research Council. Science Needs for Microbial Forensics: Initial International Research Priorities. Washington, DC: The National Academies Press, 2014.
Free download when register.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter

Evaluation of transmission risks associated with in vivo replication of several high containment pathogens in a biosafety level 4 laboratory #EBOLA

Containment level 4 (CL4) laboratories studying biosafety level 4 viruses are under strict regulations to conduct nonhuman primate (NHP) studies in compliance of both animal welfare and biosafety requirements. NHPs housed in open-barred cages raise concerns about cross-contamination between animals, and accidental exposure of personnel to infectious materials. To address these concerns, two NHP experiments were performed. One examined the simultaneous infection of 6 groups of NHPs with 6 different viruses (Machupo, Junin, Rift Valley Fever, Crimean-Congo Hemorrhagic Fever, Nipah and Hendra viruses). Washing personnel between handling each NHP group, floor to ceiling biobubble with HEPA filter, and plexiglass between cages were employed for partial primary containment. The second experiment employed no primary containment around open barred cages with Ebola virus infected NHPs 0.3 meters from naïve NHPs. Viral antigen-specific ELISAs, qRT-PCR and TCID50 infectious assays were utilized to determine antibody levels and viral loads. No transmission of virus to neighbouring NHPs was observed suggesting limited containment protocols are sufficient for multi-viral CL4 experiments within one room. The results support the concept that Ebola virus infection is self-contained in NHPs infected intramuscularly, at least in the present experimental conditions, and is not transmitted to naïve NHPs via an airborne route.

REFERENCE:
Alimonti J, et al. Evaluation of transmission risks associated with in vivo replication of several high containment pathogens in a biosafety level 4 laboratory. Scientific Reports 4, Article number: 5824.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter

Transmission of #Ebola virus from pigs to non-human primates

Ebola viruses (EBOV) cause often fatal hemorrhagic fever in several species of simian primates including human. While fruit bats are considered natural reservoir, involvement of other species in EBOV transmission is unclear. In 2009, Reston-EBOV was the first EBOV detected in swine with indicated transmission to humans. In-contact transmission of Zaire-EBOV (ZEBOV) between pigs was demonstrated experimentally. Here we show ZEBOV transmission from pigs to cynomolgus macaques without direct contact. Interestingly, transmission between macaques in similar housing conditions was never observed. Piglets inoculated oro-nasally with ZEBOV were transferred to the room housing macaques in an open inaccessible cage system. All macaques became infected. Infectious virus was detected in oro-nasal swabs of piglets, and in blood, swabs, and tissues of macaques. This is the first report of experimental interspecies virus transmission, with the macaques also used as a human surrogate. Our finding may influence prevention and control measures during EBOV outbreaks.
REFERENCE:
Weingartl HM et al. Transmission of Ebola virus from pigs to non-human primates. Scientific Reports 2 (2012), Article number: 811 doi:10.1038/srep00811
COMMENT ON:
Are we *sure* Ebola isn’t airborne?
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter

Enfermedad por el virus del #Ebola

Nota descriptiva n.°103. OMS

• El virus del Ebola causa en el ser humano la enfermedad homónima (antes conocida como fiebre hemorrágica del Ebola).
• Los brotes de enfermedad por el virus del Ebola (EVE) tienen una tasa de letalidad que puede llegar al 90%.
• Los brotes de EVE se producen principalmente en aldeas remotas de África central y occidental, cerca de la selva tropical.
• El virus es transmitido al ser humano por animales salvajes y se propaga en las poblaciones humanas por transmisión de persona a persona.
• Se considera que los huéspedes naturales del virus son los murciélagos frugívoros de la familia Pteropodidae.
• No hay tratamiento específico ni vacuna para las personas ni los animales.

Para ver el artículo completo siga el siguiente link. 

-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter

International Society for the Advancement of Cytometry Cell Sorter #Biosafety Standards

Flow cytometric cell sorting of biological specimens has become prevalent in basic and clinical research laboratories. These specimens may contain known or unknown infectious agents, necessitating precautions to protect instrument operators and the environment from biohazards arising from the use of sorters. To this end the International Society of Analytical Cytology (ISAC) was proactive in establishing biosafety guidelines in 1997 (Schmid et al., Cytometry 1997;28:99–117) and subsequently published revised biosafety standards for cell sorting of unfixed samples in 2007 (Schmid et al., Cytometry Part A J Int Soc Anal Cytol 2007;71A:414–437). Since their publication, these documents have become recognized worldwide as the standard of practice and safety precautions for laboratories performing cell sorting experiments. However, the field of cytometry has progressed since 2007, and the document requires an update. The new Standards provides guidance: (1) for laboratory design for cell sorter laboratories; (2) for the creation of laboratory or instrument specific Standard Operating Procedures (SOP); and (3) on procedures for the safe operation of cell sorters, including personal protective equipment (PPE) and validation of aerosol containment.
REFERENCE:
Kevin L. Holmes, et al. International Society for the Advancement of Cytometry Cell Sorter Biosafety Standards. Cytometry A. 2014 May; 85(5): 434–453. 
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter

#LIBRO: Cazadores de microbios

Fragmentos.

Lo que vio aquel día, es el comienzo de esta historia. El era un observador maniático; pero ¿a quién, sino a un hombre tan singular se le habría ocurrido observar algo tan poco interesante: una de las millones de gotas de agua que caen del cielo? Su hija María, de 19 años, que cuidaba cariñosamente a su extravagante padre, lo contemplaba, mientras él, completamente abstraído, cogía un tubito de cristal, lo calentaba al rojo vivo y lo estiraba hasta darle el grosor de un cabello... María adoraba a su padre. ¡Ay del vecino que se permitiera burlarse de él! Pero, ¿qué demonios se proponía hacer con ese tubito capilar? 

Ahora, nuestro distraído hombre, con ojos dilatados, rompe el tubo en pedacitos, sale al jardín y se inclina sobre una vasija de barro que hay allí para medir la cantidad de lluvia caída. Regresa al laboratorio, enfila el tubito de cristal en la aguja del microscopio...

De pronto se oye su agitada voz :

 —¡Ven aquí! ¡Rápido! ¡En el agua de lluvia hay unos bichitos! ¡Nadan! ¡Dan vueltas! ¡Son mil veces más pequeños que cualquiera de los bichos que podemos ver a simple vista! ¡Mira lo que he descubierto!

Había llegado el día de su vida de Leeuwenhoek.

-----------------------------------------------------------

Descargar:

Paul de Kruif. Cazadores de microbios. 1926

También AQUÍ.

-----------------------------------------------------------

Sigue este Blog en Facebook y Twitter
-----------------------------------------------------------

Día Mundial contra la Hepatitis, 28 de julio de 2014

DESCARGA DE POSTERS

Piénselo de nuevo

El 28 de julio de cada año, la OMS y sus asociados conmemoran el Día Mundial contra la Hepatitis con el objetivo de acrecentar la sensibilización y la comprensión de la hepatitis viral y las enfermedades que provoca. La hepatitis viral – un grupo de enfermedades infecciosas que comprende las hepatitis A, B, C, D y E – afecta a millones de personas en todo el mundo, puesto que provoca hepatopatías agudas y crónicas y causa la muerte de cerca de 1,4 millones de personas cada año. A pesar de ello, la hepatitis sigue siendo una enfermedad en gran medida olvidada o desconocida.
El Día Mundial contra la Hepatitis ofrece una oportunidad para centrar la atención en medidas específicas tales como:

• fortalecer las actividades de prevención, detección y control de la hepatitis viral y sus enfermedades conexas;
• aumentar la cobertura vacunal contra la hepatitis B e incorporar la vacuna en los programas nacionales de inmunización;
• coordinar una respuesta mundial contra la hepatitis viral.

El Día Mundial contra la Hepatitis se fijó el 28 de julio en honor del descubridor del virus de la hepatitis B, Profesor Baruch Samuel Blumberg, galardonado con el Premio Nobel, nacido ese día.
REFERENCIAS:
=> Más información (OMS) <=
=> Información de la OPS <=
--------------------------------------------
Sigue este Blog en Facebook y Twitter

Monitoring #SelectAgent Theft, Loss and Release Reports in USA

cdc.gov

The APHIS/CDC Form 3, Report of Theft, Loss or Release of Select Agents and Toxins (TLR incident report) is the mechanism by which the theft, loss or release of a biological select agent and toxin (BSAT) is reported to the United States Department of Agriculture (USDA)/Animal and Plant Health Inspection Service (APHIS) or Health and Human Services (HHS)/ Center for Disease Control and Prevention (CDC). A total of seven hundred and twenty seven (727) TLR Incident Reports were received by CDC between 2004 and 2010.

REFERENCES:
Henkel RD, et al. Monitoring Select Agent Theft, Loss and Release Reports in the United States—2004-2010. Applied Biosafety Vol. 17, No. 4, 2012:171-180.
-------------------------------------------
Sigue este Blog en Facebook y Twitter 

#LIBRO: Special Immunizations Program

The U.S. Army's Special Immunizations Program is an important component of an overall biosafety program for laboratory workers at risk of exposure to hazardous pathogens. The program provides immunizations to scientists, laboratory technicians and other support staff who work with certain hazardous pathogens and toxins. Although first established to serve military personnel, the program was expanded through a cost-sharing agreement in 2004 to include other government and civilian workers, reflecting the expansion in biodefense research in recent years. Protecting the Frontline in Biodefense Research examines issues related to the expansion of the Special Immunizations Program, considering the regulatory frameworks under which the vaccines are administered, how additional vaccines might be considered for inclusion in the Program, and factors that might influence the development and manufacturing of vaccines for the Special Immunizations Program.
REFERENCE:
National Research Council. Protecting the Frontline in Biodefense Research: The Special Immunizations Program. Washington, DC: The National Academies Press, 2011.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter

Comparison and analysis of biological agent category lists

the-scientist.com

Biological agents pose a serious threat to human health, economic development, social stability and even national security. The classification of biological agents is a basic requirement for both biosafety and biodefense. We compared and analyzed the Biological Agent Laboratory Biosafety Category list and the defining criteria according to the World Health Organization (WHO), the National Institutes of Health (NIH), the European Union (EU) and China. We also compared and analyzed the Biological Agent Biodefense Category list and the defining criteria according to the Centers for Disease Control and Prevention (CDC) of the United States, the EU and Russia. The results show some inconsistencies among or between the two types of category lists and criteria. We suggest that the classification of biological agents based on laboratory biosafety should reduce the number of inconsistencies and contradictions. Developing countries should also produce lists of biological agents to direct their development of biodefense capabilities.To develop a suitable biological agent list should also strengthen international collaboration and cooperation.
REFERENCE:
Tian D, Zheng T. Comparison and analysis of biological agent category lists based on biosafety and biodefense. PLoS One. 2014 Jun 30;9(6):e101163.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter 

El virus de #Chikungunya

La fiebre chikungunya es una enfermedad vírica transmitida al ser humano por mosquitos infectados. Además de fiebre y fuertes dolores articulares, produce otros síntomas, tales como dolores musculares, dolores de cabeza, náuseas, cansancio y erupciones cutáneas. Algunos signos clínicos de esta enfermedad son iguales a los del dengue, con el que se puede confundir en zonas donde este es frecuente. Como no tiene tratamiento curativo, el tratamiento se centra en el alivio de los síntomas. Un factor de riesgo importante es la proximidad de las viviendas a lugares de cría de los mosquitos.  A partir de 2004 la fiebre chikungunya ha alcanzado proporciones epidémicas, y es causa de considerables sufrimientos y morbilidad. La enfermedad se da en África, Asia y el subcontinente indio. En los últimos decenios los vectores de la enfermedad se han propagado a Europa y las Américas. En 2007 se notificó por vez primera la transmisión de la enfermedad en Europa, en un brote localizado en el nordeste de Italia.
En México, se ha reportado el primer caso en Junio de 2014.
REFERENCIAS:

1. Hoja informativa OMS sobre el virus chikungunya
2. Hoja informativa OPS sobre el virus chikungunya
3. Hoja de seguridad del virus de #Chikungunya

------------------------------------------
Sigue este Blog en Facebook y Twitter

Efficacy of surface #disinfectant against gram-negative #bacteria

ABSTRACT (partial).
Background. We determined the efficacy of several SDCs against clinically relevant bacterial species with and without common types of multidrug resistance.
Methods. Bacteria species used were ATCC strains; clinical isolates classified as antibiotic-susceptible; and multi-resistant clinical isolates. The five evaluated SDCs were based on alcohol and an amphoteric substance (AAS), an oxygen-releaser (OR), surface-active substances (SAS), or surface-active-substances plus aldehydes (SASA; two formulations). Bactericidal concentrations of SDCs were determined at two different contact times. Efficacy was defined as a log10 ≥ 5 reduction in bacterial cell count.
Results. SDCs based on AAS, OR, and SAS were effective against all six species irrespective of the degree of multi-resistance. The SASA formulations were effective against the bacteria irrespective of degree of multi-resistance except for one of the four P. aeruginosa isolates (VIM-1). We found no general correlation between SDC efficacy and degree of antibiotic resistance.
Conclusions. SDCs were generally effective against gram-negative bacteria with and without multidrug resistance. SDCs are therefore suitable for surface disinfection in the immediate proximity of patients. Single bacterial isolates, however, might have reduced susceptibility to selected biocidal agents.

REFERENCE:
Reichel M et al. Efficacy of surface disinfectant cleaners against emerging highly resistant gram-negative bacteria. BMC Infect Dis. 2014; 14: 292.
----------------------------------------------
Sigue este Blog en Facebook y Twitter

Placing Global #Biosecurity Engagement Programs under the Umbrella of Global Health Security

Download 1
Download 2

Global biosecurity engagement programs designed to prevent misuse of biological agents and pathogens internationally have increased dramatically under the National Strategy for Countering  Biological Threats (NSCBT), which outlined the commitment of the United States Government towards advancing health security.
But it is difficult to measure the effectiveness of these programs in improving biosecurity given that there have been relatively few attempts to misuse the life sciences. Current metrics that focus on outputs (what was done) as opposed to outcomes (the impact of what was done) have not been helpful in determining how these efforts might be improved in the future. With these metrics in mind, the goals of the programs have traditionally been more quantitative in nature – for example, increasing the number of agents secured and number of scientists engaged. Broadening the scope of biosecurity engagement metrics can help align program goals with a more qualitative approach that prioritizes the international partner’s global health security. Such an approach will be more efficient and successful in improving global and U.S. national biosecurity.

Rozo M. 2014 Placing Global Biosecurity Engagement Programs under the Umbrella of Global Health Security. Federation of American Scientists (FAS).
--------------------------------------------

Sigue este Blog en Facebook y Twitter

#VIDEO Hunting the nightmare bacteria #frontlinepbs #MEX #USA

 

Also see:  Do Hospital Workers Really Wash Their Hands?

Ver este documental en Inglés en PBS FRONTLINE

-----------------------------------------------

Sigue este Blog en Facebook and Twitter 

#LIBRO: Conceptos Básicos del Control de Infecciones 2011, ahora en Español!

Esta nueva edición de Conceptos básicos de control de infecciones de IFIC, se elaboró sobre la base de las versiones anteriores. Con un enfoque científico, profundiza y actualiza los conocimientos necesarios para sostener el desarrollo de políticas y procedimientos locales. Este libro está enfocado a las áreas hospitalarias.
Un panel internacional de expertos revisó y actualizó la mayoría de los capítulos. Además se incorporaron secciones nuevas, con el fin de asegurar que esta edición ofrecería un completo y sólido caudal de conocimientos.
REFERENCE:
IFIC’s Basic Concepts of Infection Control, 2nd Edition, 2011

PDF Download:
Español. Descarga 1             Español. Descarga 2
English1                               English2
--------------------------------------------
Sigue este Blog en Facebook y Twitter

Foto del Simposio de #Bioseguridad en Monterrey #AMexBio #sibb2014www.amexbio.org

www.amexbio.org

Conferencias sobre Biotecnología y Derecho

La ciencia y la tecnología avanzan vertiginosamente. El derecho no es indiferente a ese progreso. Temas como la modificación genética y la biotecnología deben ser analizados cuidadosamente, no sólo desde el punto de vista legal, sino también científico. Por esa razón, es importante conocer a través de especialistas los conceptos básicos que nos permitan entender el fenómeno. En tal sentido, con el ánimo de contribuir a la actualización de los miembros del Poder Judicial de la Federación y de quienes aspiran pertenecer a él, en temas de novedad e importancia significativa, se delineó el presente Ciclo de Conferencias
sobre Biotecnología y Derecho.
Al finalizar el ciclo de conferencias, el alumno:
1. Distinguirá en qué consisten los organismos genéticamente modificados.
2. Conocerá el marco jurídico aplicable en materia de bioseguridad y organismos genéticamente modificados.
3. Contará con un panorama general sobre Biotecnología e innovación científica.
Dirigido al público en general interesado en el tema.
CONVOCATORIA    -    REGISTRO

INVITA:
Instituto de la Judicatura Federal 
Escuela Judicial

AVISOS #AMEXBIO Sobre el simposio #SIBB14

AVISO 1: el día 1 de junio se cerrará el sistema de registro en línea. Si desea registrarse le pedimos que lo haga directamente en sede, pero por favor considere la disponibilidad de espacios.

AVISO 2. Quedan POCOS lugares para los cursos presimposio de:
- Planificación, Diseño y Construcción de laboratorios de Contención
- Cabinas de Seguridad Biológica
- Regulación para Organismos Genéticamente Modificados

Ya están CERRADOS (llenos) los cursos presimposio de: 
- Evaluación de Riesgos desde la perspectiva de Bioseguridad
- Comités de bioseguridad institucionales
- Desarrollo de Manuales de Bioseguridad y Biocustodia para laboratorios

Aún hay lugares en el resto de los cursos.

Recomendaciones de salud para el Mundial Brasil 2014

Diferentes organizaciones de salud emitieron recomendaciones de salud para los viajeros a la copa del mundo en Brasil en Junio. Estas recomendaciones incluyen:

1. Contratar un seguro médico del viajero, en caso de emergencias. Pregunte en su agencia de viajes. 
2. Preparar un kit de salud del viajero. Incluir medicamentos que pueden ser de utilidad en caso de emergencia, como por ejemplo: anti-histamínicos, anti-ácidos, antisépticos, repelente de mosquitos, etc.
3. VACUNAS recomendadas:

• Varicela
• Poliomelitis
• Influenza
• Sarampión, paperas, rubéola (MMR)
• Difteria, tétanos, pertusis
• Fiebre amarilla
• Rabia
• Hepatitis A y hepatitis B

VEA el resto de las recomendaciones en las siguientes páginas:

1. CDC Recomendaciones de Viajeros a la Copa Mundial Brasil 2014  PDF
2. Ministerio de Salud Argentina. Recomendaciones para viajeros al Campeonato Mundial de Fútbol Brasil  PDF
3. CDC Travel health recommendations World Cup in Brazil. 
4. Public Health England 2014 World Cup in Brazil: Health advice for fans

--------------------------------------------
Sigue este Blog en Facebook y Twitter 

Knowledge Levels Regarding Crimean-Congo Hemorrhagic Fever Among Emergency Healthcare Workers in an Endemic Region

In this study, we aimed to determine knowledge levels regarding Crimean-Congo hemorrhagic fever (CCHF) among emergency healthcare workers (HCWs) in an endemic region. A questionnaire form consisting of questions about CCHF was applied to the participants. The mean age was 29.6 ± 6.5 years (range 19 - 45). Fifty-four (49.5%) participants were physicians, 39 (35.8%) were nurses and 16 (14.7%) were paramedics. All of the participants were aware of CCHF, and 48 (44%) of them had previously followed CCHF patients. Rates of the use of protective equipment (masks and gloves) during interventions for patients who were admitted to the emergency service with active hemorrhage were 100% among paramedics, 76.9% among nurses and 61.1% among physicians (P = 0.003). Among 86 (78.9%) HCWs who believed that their knowledge regarding CCHF was adequate, 62 (56.9%) declared that they would prefer not to care for patients with CCHF (P = 0.608). The use of techniques to prevent transmission of this disease, including gloves, face masks, face visors and box coats, should be explained to emergency room HCWs, and encouragement should be provided for using these techniques.
REFERENCE
Yolcu S. et. al. Knowledge Levels Regarding Crimean-Congo Hemorrhagic Fever Among Emergency Healthcare Workers in an Endemic Region. J Clin Med Res. Jun 2014; 6(3): 197–204.
--------------------------------------------
Sigue este Blog en Facebook and Twitter

Synthetic biology revolution #podcast